| 2.62 0.22 (9.17%) | 11-21 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.38 | 1-year : | 3.8 |
| Resists | First : | 2.89 | Second : | 3.25 |
| Pivot price | 2.63  |
|||
| Supports | First : | 2.31 | Second : | 1.92 |
| MAs | MA(5) : | 2.49 |
MA(20) : | 2.67 |
| MA(100) : | 3.26 |
MA(250) : | 4.05 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 19.8 |
D(3) : | 13.6 |
| RSI | RSI(14): 46.3 |
|||
| 52-week | High : | 6.98 | Low : | 2.31 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ BTMD ] has closed above bottom band by 48.2%. Bollinger Bands are 8.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.65 - 2.66 | 2.66 - 2.67 |
| Low: | 2.35 - 2.36 | 2.36 - 2.38 |
| Close: | 2.6 - 2.62 | 2.62 - 2.64 |
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Sat, 08 Nov 2025
biote Corp. Just Beat EPS By 371%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Fri, 07 Nov 2025
Biote Corp. Navigates Challenges in Latest Earnings Call - The Globe and Mail
Wed, 05 Nov 2025
biote Corp. (BTMD) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance
Wed, 05 Nov 2025
Biote Corp (BTMD) Q3 Earnings: EPS of $0.22 Beats Estimate, Reve - GuruFocus
Wed, 05 Nov 2025
Earnings call transcript: Biote Corp Q3 2025 sees EPS beat, revenue miss - Investing.com
Tue, 04 Nov 2025
Biote Corp (BTMD) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 31 (M) |
| Shares Float | 16 (M) |
| Held by Insiders | 13.3 (%) |
| Held by Institutions | 63.7 (%) |
| Shares Short | 972 (K) |
| Shares Short P.Month | 932 (K) |
| EPS | 0.79 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2.37 |
| Profit Margin | 14.7 % |
| Operating Margin | 18.1 % |
| Return on Assets (ttm) | 21.9 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -6.7 % |
| Gross Profit (p.s.) | 4.61 |
| Sales Per Share | 6.37 |
| EBITDA (p.s.) | 1.27 |
| Qtrly Earnings Growth | -33.3 % |
| Operating Cash Flow | 40 (M) |
| Levered Free Cash Flow | 36 (M) |
| PE Ratio | 3.31 |
| PEG Ratio | 0 |
| Price to Book value | -1.11 |
| Price to Sales | 0.41 |
| Price to Cash Flow | 2.01 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|